1. Home
  2. FOR vs MGTX Comparison

FOR vs MGTX Comparison

Compare FOR & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$26.68

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

HOLD

Current Price

$12.85

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOR
MGTX
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
FOR
MGTX
Price
$26.68
$12.85
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$32.67
$24.57
AVG Volume (30 Days)
93.3K
699.6K
Earning Date
04-21-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.02
EPS
1.63
1.30
Revenue
$1,662,400,000.00
$81,391,000.00
Revenue This Year
$0.34
$141.38
Revenue Next Year
$7.73
N/A
P/E Ratio
$16.51
$10.20
Revenue Growth
10.14
144.57
52 Week Low
$22.81
$6.62
52 Week High
$32.06
$15.35

Technical Indicators

Market Signals
Indicator
FOR
MGTX
Relative Strength Index (RSI) 31.98 41.39
Support Level $26.01 $12.39
Resistance Level $27.71 $15.33
Average True Range (ATR) 0.65 0.65
MACD -0.21 -0.21
Stochastic Oscillator 4.40 7.69

Price Performance

Historical Comparison
FOR
MGTX

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: